👉At day 1 of #MunichChicagoLung Conference by #LHI (Helmholtz Munich) and SQLIFTS (Chicago), Klaus Rabe (LungenClinic Grosshansdorf) and Daiana Stolz (University of Freiburg, Germany) agreed that COPD has not ONE diagnosis method and not ONE therapy! #MunichChicagoLung

Our next speakers at #MunichChicagoLung also pointed out the heterogeneity of #COPD. Yuexin Chen (PRM, Helmholtz Munich | Helmholtz Munich | @HelmholtzMunich presented "Spatially-resolved niche proteomics of COPD " Dr. Aicha Jeridi (LHI, @HelmholtzMunich) talked about "Ferroptosis - Cell death in the absence of HMGN5"

#MunichChicagoLung by LHI (Helmholtz Munich | @HelmholtzMunich) and SQLIFTS: Ankit Bharat from Northwestern University talked about “Immune Mechanisms Of Lung Ischemia Reperfusion Injury”. Followed by Michael Gerckens (Universität München /LHI) with “From baseline to chronic lung allograft dysfunction”.

👉 Day 2 of #MunichChicagoLung Conference starts with a keynote by Soni Pullamsetti (Justus-Liebig-Universität Giessen/DZL). She shows the role of age-related epi(genetic) changes like mosaic loss of Y chromosome (mLoy) or CHIP mutations in lung diseases like #COPD or #fibrosis.

👉 Day 2 of #MunichChicagoLung Conference! All eyes on Acute Lung Injuries with 👩‍🔬Susanne Herold Lab (JustusLiebig University, Giessen). For therapeutic invervention she suggested GM-CSF Plet1 as important communication hub during lung repair.

Our #MunichChicagoLung Conference in Hohenkammer mear #Munich is not all about Eating, Drinking and looking good in a nice bavarian atmosphere. But it helps! A good place for a transatlantic collaboration in #lung research to combat #lungdiseases.

Our 2nd #MunichChicagoLung Conference at Hohenkammer was a great success!👏 💡Leading experts of lung research presented & discussed their latest findings with a special emphasis on #Environmental Perspectives on Lung Health: From prevention to therapy. Thank you all!

New PhD position to study immune and non-immune interactions in #COPD in situ and ex vivo. We will be employing multiplexed imaging, single-cell transcriptomics assays and functional evaluation using primary human cells. If you find this work as exciting as we do and you are

Excited to have Naftali Kaminski (Naftali Kaminski) at LHI/Helmholtz Munich | @HelmholtzMunich with an insightful overview of 30 years of experience in the lung fibrosis field and new insights into how the lung ages. Unforgettable citation by Naftali: “You only see things you shine the light upon!”

Can AI help in efficiently developing therapeutic compounds against #lungfibrosis? With the ”Add-on Fellowship for Interdisciplinary Life Sciences” from Joachim Herz Foundation, Kevin Merchant (Kevin Merchant) wants to find out! Bravo to the PhD in Gerald Burgstaller group at LHI!

The 2nd COPD_iNET congress kicked off with the opening talk by Yohannes Tesfaigzi and Enid, followed by a keynote address by Richard Boucher on early #COPD caused by mucin. #TogetherWeCanCure-COPD

Upcoming webinar: 12 November at 17:00 CET Taking a deeper look: epithelial responses to chronic/severe respiratory infections The webinar will improve participants' understanding of the role of respiratory cilia in host-pathogen interactions. Register: ersnet.org/events/taking-…

🛤️Paving the way on day 2 of #COPDINET2024 is Stephen Elledge (Department of Genetics, Harvard University). 🔬 His keynote is about Ubiquitin-dependent and independent control of protein degradation. 👉 copd-inet.com #COPD #HelmholtzMunich #LHI #LungResearch

🗨️“COPD is a complex disease with which needs a multi-disciplinary approach!” Do you agree with Bart Celli from Mass General Brigham in Boston? His inspiring talk at #COPDINET2024 gave a clear look on Pre-COPD. COPD_iNET Önder Yildirim Roxana Wasnick #LHI #LungResearch

#COPDINET2024 in Boston: Thanks for two days full of exchange and inspiring lectures. 👩‍🔬 👨‍🔬 💡 Closing words from this year’s organizer Yohannes Tesfaigzi Yohannes Tesfaigzi (Harvard Medical School) and Önder Yildirim Yildirim, LHI. See you next year in Munich! ☝copd-inet.com

Growing complexity of lung diseases, alongside the critical role of environmental risk factors! ☝ Find a follow-up report here on the discussions at Munich-Chicago Lung Conference in October, organized by #LHI (Helmholtz Munich | @HelmholtzMunich) and #SQLIFTS, Chicago: 👉helmholtz-munich.de/en/templates/i…

#WorldCOPDDay How to Cure #COPD?🫁 Prof. Önder Yildirim, #HelmholtzMunich and founder of COPD-iNET, collaborates with world-renowned #lung experts to cure COPD. 👇Get insights in the video #interview below!👇 💡The #LungDisease COPD is the 3rd leading cause of death globally,

📢Heute ist #WeltCOPDTag. Noch ist COPD nicht heilbar. Doch Forschende wie Önder Yildirim von Helmholtz Munich | @HelmholtzMunich arbeiten daran, dass sich dies eines Tages ändert. Wie er zukünftig COPD aufhalten will, erklärt er hier: youtu.be/G0SOHO6SjNM #COPD #Lunge

📖 🚨𝗣𝗮𝗽𝗲𝗿 𝗔𝗹𝗲𝗿𝘁🚨📖 Fantastic #LungScience project from our LHI scientists Otmar Schmid and Lin Yang_HMGU in Nature Communications. Focus: The need for precise drug delivery for #LungDiseases. 👏 Congratulations to Lin and Otmar and everyone else involved 👏

Group leaders and researchers with supervision responsibilities at #HelmholtzMunch: Become a SUPERvisor!👇